This site is intended for healthcare professionals only
LoginRegister
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionSanofi's Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer StudiesSetback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer Studies
USFDA Approves Alembics Dapagliflozin Tablets, Grants 180-Day ExclusivityAlembic Pharma Gets USFDA Nod for Paroxetine ER Tablets
Hetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ CountriesHetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ Countries
Biocon Appoints Shreehas Tambe as CEO and MD, Kedar Upadhye Named CFO Amid Business IntegrationBiocon Appoints Shreehas Tambe as CEO and MD, Kedar Upadhye Named CFO Amid Business Integration
AAP MP Flags Spurious Drugs Crisis, Seeks National Quality Authority as Paracetamol Fails CDSCO TestsAAP MP Flags Spurious Drugs Crisis, Seeks National Quality Authority as Paracetamol Fails CDSCO...
NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; DetailsNPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details
Third-Year B.Pharm Student Allegedly Jumps to Death from Hostel Building After Farewell PartyThird-Year B.Pharm Student Allegedly Jumps to Death from Hostel Building After Farewell Party
Natco Pharma to Demerge Agrochemicals Arm, Approves Nigeria Entry and Australia ExitNatco Pharma to Demerge Agrochemicals Arm, Approves Nigeria Entry and Australia Exit
Expert Panel Flags Gaps in Mascot Healths Diabetes FDC Trial, Seeks Revised Phase IV ProtocolExpert Panel Flags Gaps in Mascot Health's Diabetes FDC Trial, Seeks Revised Phase IV Protocol
Setback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early TrialSetback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early Trial
USFDA Approves Corcept Therapeutics Ovarian Cancer Drug LifyorliUSFDA Approves Corcept Therapeutics' Ovarian Cancer Drug Lifyorli
X